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http:WHAT THIS PAPER ADDS
Critical limb ischemia (CLI) needs careful clinical examination, but also assessment of the arterial circulation by
objective examinations. This prospective pilot study analyzed ankle brachial index (ABI), toe pressures (TP),
transcutaneous oxygen pressure (TcPO2), and indocyanine green ﬂuorescence imaging (ICG-FI) in the assessment
of CLI. This is the ﬁrst study evaluating the repeatability of ICG-FI and its correlation with the traditional
diagnostic tests, ABI, TP, and TcPO2.Background: Ankle brachial index (ABI), toe pressures (TP), and transcutaneous oxygen pressure (TcPO2) are
traditionally used in the assessment of critical limb ischemia (CLI). Indocyanine green (ICG) ﬂuorescence imaging
can be used to evaluate local circulation in the foot and to evaluate the severity of ischemia. This prospective
study analyzed the suitability of a ﬂuorescence imaging system (photodynamic eye [PDE]) in CLI.
Material and methods: Forty-one patients with CLI were included. Of the patients, 66% had diabetes and there
was an ischemic tissue lesion in 70% of the limbs. ABI, toe pressures, TcPO2 and ICG-ﬂuorescence imaging (ICG-FI)
were measured in each leg. To study the repeatability of the ICG-FI, each patient underwent the study twice.
After the procedure, foot circulation was measured using a time-intensity curve, where T1/2 (the time needed to
achieve half of the maximum ﬂuorescence intensity) and PDE10 (increase of the intensity during the ﬁrst 10 s)
were determined. A time-intensity curve was plotted using the same areas as for the TcPO2 probes (n¼123).
Results: The mean ABI was 0.43, TP 21 mmHg, TcPO2 23 mmHg, T1/2 38 s, and PDE10 19 AU. Time-intensity
curves were repeatable. In a Bland-Altman scatter plot, the 95% limits of agreement of PDE10 was 9.9 AU and the
corresponding value of T1/2 was 14 s. Correlation between ABI and TP was signiﬁcant (R¼.73, p<.001), and it
was weaker in diabetic patients (R¼.47, p¼.048) compared with non-diabetic patients (R¼.89, p¼.002).
Correlations between ABI and TcPO2 and TP and TcPO2 were weak (R¼.37, p¼.05 and R¼.43, p¼.037,
respectively). Correlation between TcPO2 and PDE10 was strong in diabetic patients (R¼.70, p¼.003).
Conclusions: According to this pilot study, ICG-FI with PDE can be used in the assessment of blood supply in the
ischemic foot.
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RepeatabilityINTRODUCTION
Critical limb ischemia (CLI) is the most severe form of pe-
ripheral arterial disease. Evaluation of the circulation in the
ischemic foot is crucial when methods of revascularization
are planned as well as in the assessment of the results of the
revascularization. In addition to careful clinical examination,
evaluation of the blood supply of the foot is most important.t ﬁrst authors.
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//dx.doi.org/10.1016/j.ejvs.2016.06.018Conventional methods are systolic pressure measurements
from ankle and toe level, ankle brachial index (ABI), and
transcutaneous oxygen pressure (TcPO2).
1 However, these
methods have limitations. The repeatability of TcPO2 and toe
pressure (TP) is not good,2,3 and in many cases where there
is loss of toes TP cannot be measured. ABI can be falsely high
in many cases because of mediasclerosis. In diabetic pa-
tients, assessment of circulation is more complex than in
non-diabetic patients because of the concomitant neuropa-
thy and microvascular dysfunction.
Indocyanine green ﬂuorescent imaging (ICG-FI) is a rela-
tively recent method of imaging foot perfusion, and is still
developing in many ways.4 The principle of ICG-FI is to
illuminate the tissue of interest with light at the excitation
wavelength (about 750e800 nm) while observing it at
528 M. Venermo et al.longer emission wavelengths (over 800 nm). After an
intravenous injection of ICG, perfusion of the foot can be
visualized using an infrared camera and recorded for further
analysis. The intensity of the ﬂuorescence as a function of
time can be analyzed from the recorded images allowing a
time-intensity curve to be drawn. To get comparable nu-
merical values, T1/2 and PDE10 can be determined from the
time-intensity curve.5 T1/2 is the time needed to achieve
half of the maximum ﬂuorescence intensity. PDE10 is the
intensity of the ﬂuorescence 10 s after the starting point of
uprising of the time intensity curve.5
The current prospective study tested ICG-FI in the
assessment of critically ischemic feet. The aim was to
evaluate the repeatability of the method and also to
compare how it relates with the conventional methods, ABI,
TP, and TcPO2. Furthermore, any correlation between these
methods was studied in assessment of the circulation in
critical ischemia.MATERIAL AND METHODS
Forty-one patients with critical limb ischemia treated at
Helsinki University Hospital, Department of Vascular Sur-
gery, were included in the study. Of the 41 limbs, 70% were
Fontaine stage IV, chronic limb ischemia with tissue lesion.
Of the patients, 66% had diabetes. The study was accepted
by the ethical committee of Helsinki University Central
Hospital. All patients were informed of the details of the
study and patients signed informed consent to accept
participation in the study. Exclusion criteria were allergy to
iodine, history of liver disease, and heart failure of New York
Heart Association (NYHA) classes III and IV.
ABI, toe pressures, and TcPO2 were measured in each
patient at three different points in the foot. In addition, all
patients underwent ICG-ﬂuorescence imaging twice, with at
least 30 min between the measurements. All measurements
were done by the same investigator (H.T.). A ﬂuorescence
imaging system (photodynamic eye [PDE], Hamamatsu
Photonics K.K., Hamamatsu, Japan) was used. The system
includes a 760 nm light emitting diode (LED) as an excitation
light source and a charge coupled device (CCD) camera
covered with a lens that ﬁlters out light with wavelength
below 820 nm. The method of ﬂuorescence imaging has
been described previously.3 All images were electronically
stored for later analysis. A certain range was ﬁxed on the
recorded images, which were displayed with 256 luminanceTable 1. Basic demography, Fontaine classiﬁcation, and circulation me
All (n¼41) Diabetics
Age, mean, SD (range) 73, 10.1 (58e98) 70, 10.1
Sex, female, % 31.7 21.1
Fontaine IV, % 65.9 63.1
ABI a, mean, SD (range) 0.43, 0.4 (0e1.6) 0.50, 0.3
Toe pressure, mean, SD (range) 21, 15 (0e56) 25, 14 (0
TcpO2, mean, SD (range) 23, 14 (3e48) 24, 12 (5
T1/2, mean, SD (range) 38, 24 (10e110) 33, 23 (1
PDE10, mean, SD (range) 19, 17 (1e73) 21, 19 (3
a ABI could not be measured in seven patients (one diabetic and six nintensity, and signal intensity values were plotted against
time as a time-intensity curve using regions of interest
(ROIs) analysis program (Hamamatsu Photonics K.K.,
Hamamatsu, Japan).
ICG-FI was performed in a room with no windows or
daylight and at room temperature between 20 and 25 C.
Before the examination, patients had at least 15 min of rest.
Patients were investigated in the supine position and the
PDE was set 20 cm above the dorsum of the foot. A 5 min
video recording of the foot with PDE was started after
injecting ICG (0.1 mg/kg) intravenously into the cephalic
vein.
After the procedure, the recorded images were analyzed
according to a previously described protocol.5 The ﬂuores-
cence intensity of a standard sample in the dorsum of the
foot was measured and plotted against time, and a time-
intensity curve was drawn. From this curve, the time
required to achieve half of the maximum ﬂuorescence in-
tensity was determined (T1/2). A time-intensity curve was
also plotted from small areas of the foot using the same
areas as for the TcPO2 probes. The ﬂuorescence intensity
increase was measured at 10 s (PDE10) and the PDE10 value
was compared with the TcPO2 value from the same area.
Statistical analysis
Data are expressed as mean, standard deviation, and range.
Independent variables Student t test and chi-square test
were used to test signiﬁcance between diabetic and non-
diabetic patients. A Bland-Altman scatter plot was used in
repeatability analysis. The correlation coefﬁcient was used
to describe correlation among ABI, TP, TcPO2, and PDE10. A
receiver operation characteristic (ROC) curve was used to
test PDE10 to detect severe limb ischemia at the threshold
of TcPO2 40 mmHg. In the analysis of correlation, ABI values
>1.4 were excluded as they were considered to be unreli-
able. Statistical analysis was performed using software IBM
SPSS Statistical Software version 22.0 (IMB, Armonk, NY,
USA).
RESULTS
ICG-FI measurements were successful in 41 patients. The
mean age of the patients was 73 years and one third were
female (Table 1). No allergic reactions or other side effects
were caused by ICG. The mean ABI was 0.43 (SD 0.43, range
0e1.6), TP 21 mmHg (SD15, range 0e56), TcPO2 23 mmHgasure of the study patients.
(n¼19) Non-diabetics (n¼22) p (dm vs. non-dm)
(58e98) 77, 9.0 (58e93) 0.04
31.7 0.32
68.2 0.46
5 (0.18e1.6) 0.34, 0.39 (0e1.6) 0.17
e45) 17, 15 (0e56) 0.07
e48) 21, 16 (3e46) 0.6
0e91) 42, 26 (13e110) 0.24
e73) 17, 16 (1e60) 0.24
on-diabetics) because of incompressible calf arteries.
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PDE10 19 AU (SD 19, range 1e73). ABI was >1.5 in nine
patients (20.0%). TP could not be measured in two patients
(4.4%). TcPO2 and ICG-FI were successful in all cases. Alto-
gether 123 TcPO2 values were measured from 41 patients
and PDE10 was analyzed for all 123 TcPO2 values using the
same measurement point (Fig. 1).
PDE showed patchy ischemia indicating an uneven dis-
tribution of the circulation at foot level (Fig. 1). The time-
intensity curve and thereafter T1/2 and PDE10 were
repeatable at various levels of blood supply (Fig. 2). In the
Bland-Altman scatter plot, 95% limits of agreement of
PDE10 was 9.9 AU (Fig. 2) and the corresponding value of
T1/2 was 14 s (Fig. 3).
Correlation between ABI and TP was signiﬁcant (R¼.73,
p<.001). It was weaker in diabetic patients (R¼.47, p¼.048)
compared with non-diabetic patients (R¼.89, p¼.002).
Some correlation existed between ABI and TcPO2 and TP
and TcPO2 (R¼.37, p¼.05 and R¼.43, p¼.037, respectively)
(Fig. 4), and when patients were divided according to dia-
betes status the correlation remained in non-diabetic pa-
tients (R¼.63, p¼.02 and R¼.54, p¼.04, respectively), when
in turn no correlation was seen in diabetic patients between
ABI and TcPO2 and TP and TcPO2 (R¼.005, p¼.8 and R¼.20,
p¼.11, respectively).
Correlation between ABI and PDE10 existed (R¼.42,
p¼.04) and was more clear in non-diabetic patients (R¼.58,
p¼.01) than in diabetic patients (R¼.30, p¼.055). TP andFigure 1. Fluorescence imaging of a foot with gangrene of the ﬁfth toe
drawn after ICG-FI with PDE. From these curves, PDE10 was determine
curve of a larger region (blue ROI) in the dorsal side of the foot.PDE10 had stronger correlation than ABI and PDE10 (R¼.54,
p¼.02; non-diabetic R¼.59, p¼.04, diabetic R¼.46, p¼.1).
Overall correlation between TcPO2 and PDE10 was moder-
ate (R¼.47, p¼.48), being strong in diabetic patients
(R¼.70, p¼.003) (Fig. 5) and weak in non-diabetic patients
(R¼.31, p¼.058).
In the ROC curve using TcPO2 level 40 mmHg, the cut off
value of PDE10 was 21 AU (AUC 0.73; sensitivity 67%,
speciﬁcity 72%; in diabetic patients AUC 0.83, sensitivity
88%, speciﬁcity 68%, in non-diabetic patients AUC 0.69;
sensitivity 60%, speciﬁcity 65%) (Fig. 6).DISCUSSION
Assessment of the critically ischemic foot is challenging,
especially in diabetic patients. Traditional ABI and toe
pressure are not feasible in all patients because of media-
sclerosis and in many cases missing toes. Furthermore, the
repeatability of TcPO2 and TP has been shown to be weak or
moderate.2,3 Although ICG-FI has been used for decades, for
example in ophthalmology, it has not been widely used in
vascular surgery. Yet, it gives interesting information on the
circulation of the whole foot area and gives both visual and
numeric information, which can be extracted afterwards
from recorded images of the region of interest. However, it
is important to assess the reliability and repeatability of
new examinations before implementation to clinical prac-
tice. Repeatability of the ICG-FI has not been reportedshowing the four ROIs where the time-intensity curves have been
d from three spots (left). T1/2 was derived from the time-intensity
Figure 2. Two time-intensity curves taken from the dorsum of the same foot with 30 min of each other. T1/2 has been drawn to the curve.
In the second measurement the time-intensity curve is quicker, perhaps because of some residual ICG in the body.
530 M. Venermo et al.previously. This study reports a ﬁrst experience of use of
ICG-FI in the assessment of foot level perfusion, as well as
the repeatability of the examination. The method was well
tolerated, quick to perform and feasible for all patients. PDE
showed ischemic patches on the foot, indicating variability
in the circulation at this level. Direct correlation with
traditional measures, ABI, TP, or TcPO2, varied among the
methods, which can attributed to their different perspec-
tives. The repeatability of the time-intensity curve was good
and comparable with that of other methods used to assess
foot circulation.
Indocyanine green imaging is a relatively recent imaging
method, although it has been used in some clinical appli-
cations for almost 60 years.6,7 ICG has been used for de-
cades in ophthalmology to image retinal blood vessels. ItFigure 3. (A) Bland-Altman scatterplot showing the repeatability of PD
(B) Bland-Altman scatterplot showing the repeatability of T1/2 mea
line¼95% CI without one outlier, dashed line¼95% agreement with ahas several clinically excellent properties, which have been
carefully veriﬁed during its long clinical use.8 It is non-toxic
and non-ionizing. It is ideal for angiography because it binds
efﬁciently to blood lipoproteins and thus does not leak from
circulation. Its lifetime is short, making repeated measures
possible. Also, the signal to noise ratio is good, meaning
there is not much near-infrared auto-ﬂuorescence in tissue
giving low background noise.9 Currently, there are several
devices available in the market, the median cost of the
devices being the same as in a well equipped laser Doppler
tower including tools for ABI and toe pressure measure-
ments. The cost of the actual examination is low as ICG is
not expensive. The cost of the equipment starts from 60 000
euros and the cost of ICG in one examination is less than 10
euros.E10 measurement. Horizontal lines show 95% limits of agreement.
surement. Horizontal lines show 95% limits of agreement (solid
ll values).
Figure 4. Correlation between toe pressure and TcPO2 was moderate in non-diabetic patients and did not exist in diabetic patients.
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to ensure quality control. In a preliminary report published
in 2007,10 nine patients were recruited for intra-operative
angiography using PDE. At the end of the procedure
before wound closure, ICG was injected in a central intra-
venous line reaching the leg artery about 30 s later. In eight
out of nine cases, ICG angiography showed good ﬂuores-
cent signals as the ICG passed through the graft. In one
case, no ﬂuorescence was detected and this graft was found
to be thrombosed. Kang et al. proposed a perfusion rate
model based on ICG dynamics, which they later applied to
human patients to diagnose peripheral arterial disease with
a commercially available system.11,12 The perfusion rates in
normal legs were signiﬁcantly higher compared with thoseFigure 5. Correlation between TcPO2 and PDE10 was strong in
diabetic patients.of PAOD legs and the method was also found to be sensitive
for mild cases of PAOD.11 In the current study, use of PDE
was tested in the assessment of PAOD. Unlike Kang et al.,
the focus was on critical limb ischemia. The advantage of
this method is the use of a time-intensity curve both to get
a universal measure of blood supply to the foot area (T1/2),
but also to assess circulation at different sites using PDE10.
PDE10 can be used, for example, at areas near wounds and
even at wound areas or the plantar side of the foot, which is
not possible with TcPO2. The ICG-FI does not show which
vessel supplies an ischemic area. However, the possibility of
assessing the circulation in several regions of interest af-
terwards gives interesting possibilities to study, for example,
changes in perfusion after revascularization, and thus the
success of the revascularization.
Correlation of the conventional methods, ABI, TP, and
TcPO2, with each other as well as with ICG-FI related vari-
ables, varied between strong correlation and no correlation.
This can be understood because all these methods measure
circulation at different sites. TcPO2 reﬂects local skin blood
supply. ICG-FI also describes the circulation at skin level,
and 3e5 mm below the skin. Ankle pressure and ABI gives
information on the blood pressure at ankle level, but is
affected by mediasclerosis. TP in turn gives blood pressure
very distally indicating the level of ischemia there, which
may differ from tissue blood supply in the dorsum of the
foot. This can be confusing however, as they may give
different answers on the severity of the ischemia. All these
measures are used in the assessment of circulation in the
critically ischemic foot and each has strengths and weak-
nesses. ICG-FI with PDE is an additional tool in this
assessment. It can be used in all patients, despite for
example, the lack of toes or a wound in the foot. An
additional advantage over the other methods is the recor-
ded visual image of the foot area that gives information on
variation of ﬂuorescence intensity, that is blood supply at
different sites. As analysis is done after image recording
Figure 6. Receiver operation characteristic (ROC) curves for PDE10 to detect severe limb ischemia at the threshold of TcPO2 40 mmHg;
sensitivity 60% and speciﬁcity 65% for non-diabetic patients (A); sensitivity 88% and speciﬁcity 68% for the diabetic patients (B).
532 M. Venermo et al.using software which creates a time-intensity curve, several
regions of interest can be measured, and later new regions
of interests can be added. The study is also independent of
the operator, so no inter-observer variability exists. In dia-
betic patients media sclerosis does not have an impact on
the results.
Repeatability of a measurement is important when used
in clinical decision making, considering therapeutic options,
and evaluating the inﬂuence of therapy, as well as when
assessing the progress of the disease. All the methods, ABI,
TP, and TcPO2, have limitations regarding reproduc-
ibility.2,3,13,14 In a study by de Graaff et al. evaluating intra-
observer repeatability, the 95% limits of agreement for ABI
was 0.09, toe pressure 10 mmHg, and TcPO2 14 mmHg.
14 In
the authors’ previous study on the repeatability of TP, the
95% limit of agreement was 38 mmHg. The 95% limit of
agreement for PDE10 was 9.8 AU and for T1/2 14 s. These
are comparable or better than the values of the other
methods. T1/2 tended to be systematically shorter in the
second measurement (Fig. 1), probably because of some
residual ICG in the body from the ﬁrst imaging. Similarly,
PDE10 values tended to be higher in the second round,
which could be explained by the same hypothesis.
Although ICG-FI is easy to use and seems to give reliable
information, it has certain pitfalls and limitations. For
example, inﬂammation caused by infection in the foot in-
creases microcirculation and this leads to increased ﬂuo-
rescence intensity and T1/2 and PDE10 values that are too
high. Furthermore, the inﬂuence of low cardiac output is
unknown and long T1/2 may be partially related to slow
circulation rather than stenosis or occlusions in the lower
extremity arteries. PDE is not completely non-invasive,
because intravenous access is needed to get the images.
Furthermore, the device used in this study was difﬁcult toset up for the imaging and it took time to draw the time-
intensity curve and to extract the T1/2 and PDE10 values.
In the current study, as well as in earlier reports, ICG has
been extremely well tolerated, but although very rare,
allergic reaction is possible.15
This study has several limitations. The number of patients
is small and thus this can only be seen as a pilot assess-
ment. This was because the availability of the assessment
and study period was limited. The study does not have a
control group with normal circulation, which would allow
analysis of the threshold values for CLI. Further research is
needed to evaluate the value of ICG-FI in predicting wound
healing, determining the optimal amputation level, and in
the assessment of the success of revascularization. So far,
ICG-FI is not widely used. One possible reason is that
vascular surgeons are not familiar with the method and its
interpretation. The concept is old, but the ﬁrst generation
devices do not include reporting software, which is avail-
able in the newer devices. Newer ICG-FI equipment has
quick reporting programs which create immediate time-
intensity curves, allowing performance of the whole
assessment process from the beginning of the examination
until the report is ready, in 15 min. The most interesting
future research area is quality control of the revasculariza-
tion using ICG-FI.
In conclusion, according to this pilot study, ICG-FI with
PDE can be used in the assessment of blood supply in the
ischemic foot. It is quick to perform, well tolerated, and
feasible. In addition to the quantitative evaluation, it gives a
visual image of the variation in circulation at foot level. The
small number of patients and lack of control group mean
that the power of the study is limited and further research
is needed to evaluate the threshold values for CLI and the
accuracy of the examination.
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